sanofi cfo details earnings, covid-19 vaccine outlook, and drug development
Published 2 years ago • 58K plays • Length 8:20Download video MP4
Download video MP3
Similar videos
-
7:48
sanofi ceo on breakthroughs in cancer research, covid-19 vaccine development, and drug pricing
-
2:29
sanofi expecting for approval on covid-19 vaccine in the beginning of 2021, also european markets up
-
0:45
u.s. likely to get sanofi's covid-19 vaccine first if it succeeds
-
6:15
70 coronavirus vaccines in development globally: who
-
0:16
tech companies that are requiring proof of covid-19 vaccination
-
6:26
sanofi has two covid vaccines in clinical trials
-
1:36
sanofi ceo on coronavirus vaccine development and the pressure 'to get it right'
-
6:04
sanofi ceo on two-pronged approach to developing covid-19 vaccine
-
10:09
we’ll have about 600-800 million coronavirus vaccines available in early 2021: johnson & johnson cfo
-
3:35
covid vaccine will be available by the end of 2021: sanofi ceo
-
0:54
sanofi drops vaccine bid amid rivals' success
-
2:13
sanofi halts development of its covid mrna vaccine
-
1:42
fda re-strategizes covid-19 vaccine rollout in 2023
-
5:41
covid-19: vaccines for omicron are ‘already priced into covid stocks’: jefferies managing director
-
9:00
coronavirus vaccine: when it could be available and challenges
-
6:34
who should get an updated covid-19 booster? doctor explains
-
7:35
understanding coronavirus, herd immunity, and the covid-19 vaccine
-
1:20
sanofi, gsk launch trial for covid-19 vaccine
-
4:13
sanofi ceo paul hudson on cancer research, covid-19 vaccine and more